Novocuff, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Novocuff, Inc. - overview
Established
2021
Location
San Luis Obispo, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, and founded in 2021 by CEO and co-founder Amelia Degenkolb, Novocuff, Inc. operates as a provider of minimally invasive devices intended to prevent preterm births by supporting healthcare professionals in improving pregnancy outcomes. In June 2024, Novocuff, Inc. raised USD 6.
76 million in series A funding led by AXA IM Alts, with participation from Avestria Ventures, Laborie Medical Technologies Corp. , Laerdal Million Lives Fund, March of Dimes Foundation, and RH Capital Partners. The company provides a wide range of medical device solutions such as devices to delay labor for both singleton and multiple gestation pregnancies. Moreover, the firm's offerings include minimally invasive, non-surgical devices to stabilize and close the cervix, retain amniotic fluid, and sustain cervical length to extend pregnancy duration.
Current Investors
AXA Investment Managers, March of Dimes Foundation, Laborie Medical Technologies Corp.
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.novocuff.com/
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.